Redeye is positive to the news that Waystream continues to receive orders from City networks.
This morning, Vow announced a modification order for a hybrid heating system on a hot-dip galvanisin...
Duell released a profit warning ahead of the FY 2023 earnings which will be published 9th of October...
Redeye comments on its key takes from EG7's CMD where it announced new financial targets implying st...
Redeye comments on the additional data presented from the phase IIa study with ACD440 in neuropathic...
Redeye comments on the announcement of another collaboration for a bacterial vaccine candidate, this...
Recently (Monday Sep 18), those who had purchased more expensive special editions of Payday 3 were g...
På måndagen hade de som köpt dyrare specialutgåvor av Payday 3 förtur att spela spelet.
Redeye comments on Ortoma’s agreement with DePuy Synthes.
Redeye envisions an exciting period on the horizon for Xspray Pharma following the resolution of the...
We have now included acute myeloid leukaemia (AML) and myelodysplastic syndrome (MDS) in our sum-of-...
PolarCool meddelade idag den 19 september att bolaget har tecknat ett avtal med Eisbären Berlin, vil...
Today, BankNordik upgraded its FY 2023E net profit guidance from DKK 235-265m to DKK 260-290m, corre...
Redeye comments on Scandinavian ChemoTech’s distribution agreement with Lambertis Corporation AS in ...
Redeye provides a comment on the announcement of a potential indication expansion made by Initiator ...
Biovica has signed the first direct commercial client bill agreement with a larger healthcare provid...
STENOCARE announced on September 18th a market update highlighting progress in several areas, includ...
Etteplan issued a profit warning and lowered its guidance for FY 2023.
Redeye leaves a comment on yesterday’s announcement stating that Newbury has successfully signed a S...
Strides in tungsten and titanium processing Commercialised sales organisation will drive order flow ...
